Ambit Capital Starts Senores Pharmaceuticals (SENORES:IN) at Buy (1)Ambit Capital analyst Prashant Nair initiates coverage on Senores Pharmaceuticals (SENORES:IN) with a Buy (1) rating and a price target of INR880.00.
Ambit Capital Starts Senores Pharmaceuticals (SENORES:IN) at Buy (1)Ambit Capital analyst Prashant Nair initiates coverage on Senores Pharmaceuticals (SENORES:IN) with a Buy (1) rating and a price target of INR880.00.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -5.50% per trade.
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +14.00% per trade.
Copying Prashant Nair's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +56.80% per trade.
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +59.10% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
SENORES Analyst Recommendation Trends
Rating
Apr 25
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
total
1
In the current month, SENORES has received 1Buy Ratings, 0Hold Ratings, and 0Sell Ratings. SENORES average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.
SENORES Stock Forecast FAQ
What is IN:SENORES’s average 12-month price target, according to analysts?
Currently, no data Available
What is IN:SENORES’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IN:SENORES, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Senores Pharmaceuticals Ltd. a Buy, Sell or Hold?
Currently, no data Available
What is Senores Pharmaceuticals Ltd.’s share price target?
Currently, no data Available
What do analysts say about Senores Pharmaceuticals Ltd.?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Senores Pharmaceuticals Ltd.?
To buy shares of IN:SENORES, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.